CRISI Medical Systems, a San Diego-based medical technology company dedicated to improving the safety and delivery of IV injectable medications, is pleased to announce that we joined BD (Becton, Dickinson and Company), a leading global medical technology company based in Franklin Lakes, NJ, on March 2, 2015. For more information, please click here.

BD and CRISI entered into an exclusive partnership in June 2013 to jointly develop the BD Intelliport™ Medication Management System, a first-of-its-kind medication management solution for IV bolus injections. The BD Intelliport™ Medication Management System is the first and only solution to provide real-time drug identification, dose measurement and allergy alerts at the point of injection while wirelessly sending captured information directly into the patient’s electronic medical record (EMR) following medication administration.

To learn more about the BD Intelliport™ Medication Management System, please click here.